These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 32559792)

  • 1. Screening for Preeclampsia in the First Trimester and Aspirin Prophylaxis: Our First Year.
    Lourenço I; Gomes H; Ribeiro J; Caeiro F; Rocha P; Francisco C
    Rev Bras Ginecol Obstet; 2020 Jul; 42(7):390-396. PubMed ID: 32559792
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The International Federation of Gynecology and Obstetrics (FIGO) initiative on pre-eclampsia: A pragmatic guide for first-trimester screening and prevention.
    Poon LC; Shennan A; Hyett JA; Kapur A; Hadar E; Divakar H; McAuliffe F; da Silva Costa F; von Dadelszen P; McIntyre HD; Kihara AB; Di Renzo GC; Romero R; D'Alton M; Berghella V; Nicolaides KH; Hod M
    Int J Gynaecol Obstet; 2019 May; 145 Suppl 1(Suppl 1):1-33. PubMed ID: 31111484
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Implementation of Preeclampsia Screening and Prevention (IMPRESS) Study.
    Johnson JM; Walsh JD; Okun NB; Metcalfe A; Pastuck ML; Maxey CM; Soliman N; Mahallati H; Kuret VH; Dwinnell SJ; Chada R; O'Quinn CP; Schacher J; Somerset DA; Paterson K; Suchet IB; Silang KA; Paul H; Nerenberg KA; Johnson DW
    Am J Obstet Gynecol MFM; 2023 Feb; 5(2):100815. PubMed ID: 36400421
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Usefulness of aspirin therapy in high-risk pregnant women with abnormal uterine artery Doppler ultrasound at 14-16 weeks pregnancy: randomized controlled clinical trial.
    Ebrashy A; Ibrahim M; Marzook A; Yousef D
    Croat Med J; 2005 Oct; 46(5):826-31. PubMed ID: 16158479
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of early supplementation with low-dose aspirin on functional first trimester parameters in low-risk pregnancies.
    Zvanca ME; Bot M; Radu D; Radu N; Petca A
    J Matern Fetal Neonatal Med; 2019 Feb; 32(4):604-609. PubMed ID: 28974130
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-effectiveness of first-trimester screening with early preventative use of aspirin in women at high risk of early-onset pre-eclampsia.
    Ortved D; Hawkins TL; Johnson JA; Hyett J; Metcalfe A
    Ultrasound Obstet Gynecol; 2019 Feb; 53(2):239-244. PubMed ID: 29700870
    [TBL] [Abstract][Full Text] [Related]  

  • 7. First trimester preeclampsia screening and prediction.
    Chaemsaithong P; Sahota DS; Poon LC
    Am J Obstet Gynecol; 2022 Feb; 226(2S):S1071-S1097.e2. PubMed ID: 32682859
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevention of preeclampsia with aspirin.
    Rolnik DL; Nicolaides KH; Poon LC
    Am J Obstet Gynecol; 2022 Feb; 226(2S):S1108-S1119. PubMed ID: 32835720
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A new model for screening for early-onset preeclampsia.
    Serra B; Mendoza M; Scazzocchio E; Meler E; Nolla M; Sabrià E; Rodríguez I; Carreras E
    Am J Obstet Gynecol; 2020 Jun; 222(6):608.e1-608.e18. PubMed ID: 31972161
    [TBL] [Abstract][Full Text] [Related]  

  • 10. First-trimester risk factors for preeclampsia development in women initiating aspirin by 16 weeks of gestation.
    Block-Abraham DM; Turan OM; Doyle LE; Kopelman JN; Atlas RO; Jenkins CB; Blitzer MG; Baschat AA
    Obstet Gynecol; 2014 Mar; 123(3):611-617. PubMed ID: 24513777
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aspirin for Evidence-Based Preeclampsia Prevention trial: effect of aspirin in prevention of preterm preeclampsia in subgroups of women according to their characteristics and medical and obstetrical history.
    Poon LC; Wright D; Rolnik DL; Syngelaki A; Delgado JL; Tsokaki T; Leipold G; Akolekar R; Shearing S; De Stefani L; Jani JC; Plasencia W; Evangelinakis N; Gonzalez-Vanegas O; Persico N; Nicolaides KH
    Am J Obstet Gynecol; 2017 Nov; 217(5):585.e1-585.e5. PubMed ID: 28784417
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aspirin Use to Prevent Preeclampsia and Related Morbidity and Mortality: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.
    Henderson JT; Vesco KK; Senger CA; Thomas RG; Redmond N
    JAMA; 2021 Sep; 326(12):1192-1206. PubMed ID: 34581730
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical implementation of pre-eclampsia screening in the first trimester of pregnancy.
    Cordisco A; Periti E; Antoniolli N; Lozza V; Conticini S; Vannucci G; Masini G; Pasquini L
    Pregnancy Hypertens; 2021 Aug; 25():34-38. PubMed ID: 34051436
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Study protocol for the randomised controlled trial: combined multimarker screening and randomised patient treatment with ASpirin for evidence-based PREeclampsia prevention (ASPRE).
    O'Gorman N; Wright D; Rolnik DL; Nicolaides KH; Poon LC
    BMJ Open; 2016 Jun; 6(6):e011801. PubMed ID: 27354081
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Baseline placental growth factor levels for the prediction of benefit from early aspirin prophylaxis for preeclampsia prevention.
    Moore GS; Allshouse AA; Winn VD; Galan HL; Heyborne KD
    Pregnancy Hypertens; 2015 Oct; 5(4):280-6. PubMed ID: 26597741
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomized controlled trial of low-dose aspirin for the prevention of preeclampsia in women at high risk in China.
    Lin L; Huai J; Li B; Zhu Y; Juan J; Zhang M; Cui S; Zhao X; Ma Y; Zhao Y; Mi Y; Ding H; Chen D; Zhang W; Qi H; Li X; Li G; Chen J; Zhang H; Yu M; Sun X; Yang H
    Am J Obstet Gynecol; 2022 Feb; 226(2):251.e1-251.e12. PubMed ID: 34389292
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of two-risk assessment algorithms for preeclampsia in first trimester with consecutive intake of low-dose aspirin in the high-risk group - an observational study.
    Lakovschek IC; Csapo B; Kolovetsiou-Kreiner V; Mayer-Pickel K; Reif P; Stern C; Ulrich D; Lang U; Obermayer-Pietsch B; Cervar-Zivkovic M
    J Matern Fetal Neonatal Med; 2018 Mar; 31(5):549-552. PubMed ID: 28162023
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Implementation of routine first trimester combined screening for pre-eclampsia: a clinical effectiveness study.
    Guy GP; Leslie K; Diaz Gomez D; Forenc K; Buck E; Khalil A; Thilaganathan B
    BJOG; 2021 Jan; 128(2):149-156. PubMed ID: 32613730
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ASPRE trial: performance of screening for preterm pre-eclampsia.
    Rolnik DL; Wright D; Poon LCY; Syngelaki A; O'Gorman N; de Paco Matallana C; Akolekar R; Cicero S; Janga D; Singh M; Molina FS; Persico N; Jani JC; Plasencia W; Papaioannou G; Tenenbaum-Gavish K; Nicolaides KH
    Ultrasound Obstet Gynecol; 2017 Oct; 50(4):492-495. PubMed ID: 28741785
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prospective evaluation of screening performance of first-trimester prediction models for preterm preeclampsia in an Asian population.
    Chaemsaithong P; Pooh RK; Zheng M; Ma R; Chaiyasit N; Tokunaka M; Shaw SW; Seshadri S; Choolani M; Wataganara T; Yeo GSH; Wright A; Leung WC; Sekizawa A; Hu Y; Naruse K; Saito S; Sahota D; Leung TY; Poon LC
    Am J Obstet Gynecol; 2019 Dec; 221(6):650.e1-650.e16. PubMed ID: 31589866
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.